Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma
Table 1
Baseline characteristics of patients with and without bacterial infection among patients with fever after TACE and/or RFA.
Characteristics
Patients with fever after TACE and/or RFA
With bacterial infection ()
Without bacterial infection ()
value
Male
7 (78)
67 (76)
>0.999
Age
73 (61–78)
63 (57–72)
0.072
Comorbidities
Diabetes
4 (44)
32 (36)
0.723
Chronic lung disease
0 (0.0)
1 (1)
>0.999
Chronic kidney disease
0 (0.0)
13 (14.8)
0.603
Etiology of liver cirrhosis
HBV
5 (56)
53 (61)
0.863
HCV
1 (11)
15 (17)
Both HBV and HCV
0 (0)
2 (2)
Alcohol
3 (33)
17 (19)
Unknown etiology
0 (0)
1 (1)
Child-Pugh score
A
7 (78)
78 (89)
0.308
B
2 (22)
10 (11)
C
0 (0)
0 (0)
Ascites
3 (33)
10 (11)
0.099
Previous variceal bleeding
2 (22)
6 (7)
0.160
Previous hepatectomy
0 (0)
6 (7)
>0.999
TNM stage
I
2 (22)
21 (24)
0.103
II
3 (33)
42 (48)
IIIA
0 (0)
14 (16)
IIIB
4 (44)
9 (10)
IVA
0 (0)
1 (1)
IVB
0 (0)
1 (1)
Number of tumor
Solitary
2 (22)
24 (27)
>0.999
Multiple
7 (78)
64 (73)
Intervention
TACE
7 (78)
59 (67)
0.847
RFA
1 (11)
21 (24)
Sequential TACE and RFA
1 (11)
8 (9)
Total dose of injected Adriamycin (mg)
20.0 (20–20)
20.0 (20–20)
0.780
TDD
26.5 (25–30)
26.0 (25–30)
0.911
Expressed as median (interquartile range); 8 patients of TACE; 68 patients. TACE: transarterial chemoembolization; RFA: radiofrequency ablation; TDD: total dose delivered of TACE (Adriamycin (mg) + dose of iodized oil (mL)); HBV: hepatitis B virus; HCV: hepatitis C virus.
